logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
X

Xianjun Yu

fudan university

85H-index
937Paper Count
3.2WCitation Count
Published Papers 309
Publication Date
logo
GMPS drives pancreatic cancer progression via suppressing DNA damage, STING activation and cellular senescence
errTranslational Oncology
IF4.1
err2026-09-21
err0
errOAAI
errYangyi Li; Zifeng Zhang; Dingru Li; Cong Zhou; Yueyue Chen; Chunbin Zhu; Jianhui Yang; Rong Tang; Wei Wang; Xianjun Yu; Jin Xu
errShare
errSave
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
errCancer Cell
IF44.5
err2026-09-16
err0
errOAAI
errSi Shi; Miaoyan Wei; Nan Du; Jialin Li; Boyue Han; Wei Wang; Xin Hu; Fei Luo; Jin Xu; Xianjun Yu
errShare
errSave
Corrigendum to “Wang X, Wang R, Lin X et al. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancreatic cancer organoids” [Pancreatology (2026), 26(6), 896-907]
errPancreatology
IF2.7
err2026-09-04
err0
errOAAI
errXu Wang; Ruijie Wang; Xuan Lin; Xuan Zou; Yusheng Chen; Mingjian Ma; Mengxing Pan; Jinxin Chen; Yu Yan; Fei Ding; Shuai Zhou; Xianjun Yu; Chen Liu; Xu Wang; He Cheng
errShare
errSave
Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancreatic cancer organoids
errPancreatology
IF2.7
err2026-08-01
err0
PREAI
errWang, Xu; Wang, Ruijie; Lin, Xuan; Zou, Xuan; Chen, Yusheng; Ma, Mingjian; Pan, Mengxing; Chen, Jinxin; Yan, Yu; Ding, Fei; Zhou, Shuai; Yu, Xianjun; Liu, Chen; Wang, Xu.; Cheng, He
errShare
errSave
Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer
errCancer Cell
IF44.5
err2026-06-11
err0
errOAAI
errRong Tang; Liquan Jin; Chen Chen; Yingna Liao; Dingru Li; Yangyi Li; Yueyue Chen; Yuan Liu; Qiong Du; Zeyin Rong; Jiaoshun Chen; Yubin Lei; Zijian Wu; Zhen Tan; Yufeng Wang; Haoyu Wang; Jin Xu; Wei Wang; Si Shi; Xianjun Yu
errShare
errSave
The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy
errOncogenesis
IF6.4
err2026-06-02
err0
errOAAI
errZheng Wu; Rong Tang; Jin Xu; Yufeng Wang; Liquan Jin; Yingna Liao; Dingru Li; Cheng Zu; Chengkai Yang; Xianjun Yu; Si Shi
errShare
errSave
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer
errNature Communications
IF15.7
err2026-05-28
err0
errOAAI
errRong Tang; Yangyi Li; Cong Zhou; Chunbin Zhu; Chen Chen; Liquan Jin; Yueyue Chen; Yingna Liao; Yuan Liu; Qiong Du; Yubin Lei; Zijian Wu; Jin Xu; Wei Wang; Xiaoyu Yin; Chenghao Shao; Si Shi; Xianjun Yu
errShare
errSave
Reply to Jiang and Zhao
errGastroenterology
IF25.1
err2026-05-25
err0
PREAI
errZhilong Ma; Xianjun Yu; Si Shi
errShare
errSave
Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer
errAdvanced Science
IF14.1
err2026-04-13
err0
errOAAI
errChen Chen; Dingru Li; Yingna Liao; Zehua Wang; Chunbin Zhu; Zifeng Zhang; Liquan Jin; Yueyue Chen; Jiaoshun Chen; Junyi Xu; Miaoyan Wei; Rong Tang; Xianjun Yu; Si Shi
errShare
errSave
RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling (vol. 52, pg. 1105, 2018)
errInternational Journal of Oncology
IF4.9
err2026-01-01
err0
PREAI
errQi, Zi-Hao; Xu, Hua-Xiang; Zhang, Shi-Rong; Xu, Jin-Zhi; Li, Shuo; Gao, He-Li; Jin, Wei; Wang, Wen-Quan; Wu, Chun-Tao; Ni, Quan-Xing; Yu, Xian-Jun; Liu, Liang
errShare
errSave
A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma
errSignal Transduction and Targeted Therapy
IF52.7
err2025-12-20
err0
errOAAI
errRan Xue; Miaoyan Wei; Jiajia Yuan; Zhihua Li; Yuhong Zhou; Zeyun Xue; Yiwen Wu; Hongxia Han; Jun Zhou; Xianjun Yu; Lin Shen
errShare
errSave
Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors
errCell Death & Disease
IF9.6
err2025-12-13
err0
errOAAI
errXin Lou; Yihua Shi; Yi Qin; Wuhu Zhang; Zeng Ye; Fei Wang; Yan Wang; Tian Ding; Desheng Jing; Guixiong Fan; Yue Zhang; Xuemin Chen; Xiaowu Xu; Xianjun Yu; Shunrong Ji; Junfeng Xu
errShare
errSave
The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer
errTranslational Oncology
IF4.1
err2025-12-02
err0
errOAAI
errJianhui Yang; Jiang Liu; Zeyin Rong; Zhen Tan; Wei Wang; Qingcai Meng; Miaoyan Wei; Jie Hua; Bo Zhang; Xianjun Yu; Jin Xu; Chen Liang
errShare
errSave
Mapping of Lymph Node Metastasis in Nonfunctional Pancreatic Neuroendocrine Tumors: A retrospective analysis of 455 patients
errPancreatology
IF2.7
err2025-11-06
err0
PREAI
errFei Wang; Wei Tang; Chenjie Zhou; Zheng Li; Jie Chen; Xiaowu Xu; Xianjun Yu; Shunrong Ji
errShare
errSave
m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
errCell Death & Disease
IF9.6
err2025-11-03
err0
errOAAI
errZhen Tan; Jianhui Yang; Yueyue Chen; Heng Zhu; Xiaomeng Liu; He Xu; Qingcai Meng; Mingming Xiao; Rong Tang; Zeyin Rong; Xianjun Yu; Chen Liang; Jin Xu
errShare
errSave
A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-10-24
err0
PREAI
errChunjuan Jiang; Miaoyan Wei; Panli Li; Silong Hu; Xiaoping Xu; Jindian Li; Dan Huang; Weiwei Weng; Xianjun Yu; Shaoli Song
errShare
errSave
Global burden of early-onset pancreatic cancer attributable to metabolic risks from 1990 to 2021; and projections to 2030
errFrontiers in Oncology
IF3.3
err2025-10-15
err0
errOAAI
errYingjin Fang†; Yile Xu†; Faliang Xing†; Weixin Zhang†; Chen Liang; Qingcai Meng; Jialin Li; Jin Xu; Wei Wang; Yi Qin; Xianjun Yu; Bo Zhang
errShare
errSave
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer
errCell Reports Medicine
IF10.6
err2025-09-19
err0
errOAAI
errSi Shi; Jian Zhang; Rujiao Liu; Shuiping Gao; Jin Xu; Wei Wang; Miaoyan Wei; Jialin Li; Chen Liu; Xiaowu Xu; Wentao Pan; Xiaohong Tian; Lichuang Men; Hengbang Wang; Zhiyan Liang; Min Zhu; Dajun Yang; Yifan Zhai; XianJun Yu
errShare
errSave
Liquid-Liquid Phase Separation in Major Hallmarks of Cancer
errCELL PROLIFERATION
IF5.6
err2025-09-01
err0
errOAAI
errXie, Chen-chen; Wang, Ting; Liu, Xin-ran; Wang, Yan; Dang, Qin; Ding, Tian; Xu, Jia-qi; Yu, Xian-jun; Lin, Hai; Xu, Xiao-wu; Qin, Yi
errShare
errSave
Antitumor potential of polyamines in cancer
errACTA BIOCHIMICA ET BIOPHYSICA SINICA
IF3.4
err2025-09-01
err1
PREAI
errLiu, He; Liu, Yi; Wang, Xinyue; Xiao, Zhiwen; Ni, Quanxing; Yu, Xianjun; Luo, Guopei
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
余君 cover
余君 (Jun Yu)
H-index: 133 · Papers: 1.8K
王
王萍 (Ping Wang)
H-index: 105 · Papers: 2.1K
C
Chen Liu
H-index: 104 · Papers: 1.8K
沈
沈洪兵 (Hongbing Shen)
H-index: 100 · Papers: 1.1K
Huamin Wang cover
Huamin Wang (Huamin Wang)
H-index: 95 · Papers: 633
View more